Evidence supporting the use of: Resveratrol
For the health condition: Multiple Sclerosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 1

Resveratrol is a polyphenolic compound found in foods like grapes, berries, and peanuts, and has attracted attention for its antioxidant and anti-inflammatory properties. In the context of Multiple Sclerosis (MS), resveratrol is not used traditionally; its use is based on early-stage scientific research. Preclinical studies (mostly in animal models) suggest that resveratrol may exert neuroprotective effects, possibly by activating sirtuin-1 (SIRT1), reducing oxidative stress, and modulating immune responses. For example, some mouse studies have shown that resveratrol can reduce the severity of experimental autoimmune encephalomyelitis (EAE), the standard animal model for MS. These effects are thought to relate to downregulation of pro-inflammatory cytokines and inhibition of pathological immune cell activity.

However, human studies are extremely limited. There are only a handful of small trials or case reports involving MS patients, and these have not provided strong or consistent evidence for efficacy. Most clinical evidence for resveratrol is indirect or based on related neurological or inflammatory conditions. No major health organizations currently recommend resveratrol for MS treatment or support.

In summary, while laboratory research suggests that resveratrol might have mechanisms relevant to MS pathophysiology, there is inadequate clinical evidence to support its use for this condition. Therefore, resveratrol’s use in MS is experimental, and its efficacy and safety for MS patients remain unproven.

More about resveratrol
More about Multiple Sclerosis